evaluate novo nordisk on glp-1 agonists signs pact to assess semaglutide implant GLP-1 Competitive Environment - Citrini
Description
The response of different patients to GLP-1RAs may be different, and some patients may not be able to achieve the expected hypoglycemic effect
Between 10 percent and a quarter experienced vomiting, depending on the dose
Results Eight studies comprised of 715 children and adolescents were included
10.1186/s12944-017-0572-9 52
There is also evidence that GLP-1RA has positive effect on metabolic syndrome and abdominal obesity
Before we discuss these drugs further, a quick reminder that it's always best to seek medical advice from healthcare providers about what may or may not be right for you
